Ketotifen Teva (Ketotifen)

Ketotifen blocks H1 histamine receptors, preventing histamine from causing typical allergy symptoms such as itching, swelling, and redness. It also stabilises mast cells, reducing the release of inflammatory mediators like leukotrienes and prostaglandins, which helps control both early and late allergic reactions.

The appropriate dose of Ketotifen Teva is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for ketotifen in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To order Ketotifen Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketotifen combines H1‑receptor antagonism with mast‑cell stabilisation, offering both immediate allergy relief and longer‑term prophylaxis. Unlike many first‑generation antihistamines that only block histamine, ketotifen’s dual action can be advantageous for patients needing both symptom control and asthma prevention.

Ketotifen Teva should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ketotifen Teva is taken orally, usually as a tablet. It should be swallowed with a full glass of water, and can be taken with or without food as directed by the prescriber. Consistency in timing helps maintain steady blood levels.

Serious risks include rare but severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and blood disorders like agranulocytosis. Patients should seek immediate medical attention if they notice unexplained rash, jaundice, fever, or signs of infection.

Ketotifen Teva should not be used by individuals with known hypersensitivity to ketotifen or any of its excipients. Caution is also advised for patients with severe liver impairment, glaucoma, or those taking interacting medications listed under major or moderate interactions.